Publications by authors named "Kevin Scanlon"

Claim this Profile
C
Commercializing medical technology.
Kevin J Scanlon, Mark A Lieberman

Cytotechnology· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-genes: siRNA, ribozymes and antisense.
Kevin J Scanlon

Curr Pharm Biotechnol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and transfection of a ribozyme targeting human caspase-3.
Deirdre Cronin, Carmel Daly, Toni O'Doherty, Mary Heenan, Kevin J Scanlon

Anticancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer gene therapy: challenges and opportunities.
Kevin J Scanlon

Anticancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
Hiroshi Kijima, Hitoshi Yamazaki, Masato Nakamura, Kevin J Scanlon, R Yoshiyuki Osamura

Int J Oncol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies.
Robert J Morgan, Edward M Newman, Lawrence Sowers, Kevin Scanlon, Jonathan Harrison

Cancer Chemother Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
Junko Nagata, Hiroshi Kijima, Hiroyuki Hatanaka, Satomi Asai, Hayato Miyachi, Kevin J Scanlon

Int J Oncol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis